Goldman Sachs Considers Implications For Regeneron, Amgen, Sanofi Following PCSK9 Ruling
March 17, 2016 at 07:45 AM EDT
The US District Court jury has ruled in favor of Amgen, Inc. (NASDAQ: AMGN) in the PCSK9 patent litigation. Both Amgen’s ...
